Nicholas S Roetker
Overview
Explore the profile of Nicholas S Roetker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knapp C, Horak K, Roetker N, Fink A, Gao A, Johansen K, et al.
Kidney360
. 2024 Dec;
PMID: 39625788
Background: The prevalence of depression is high in the chronic kidney disease (CKD) (20-40%) and dialysis (30-50%) populations. Less is known about how depressive symptoms change over time in patients...
2.
Repp A, Sparks A, Wilkinson K, Roetker N, Schaefer J, Li A, et al.
J Thromb Haemost
. 2024 Sep;
22(12):3521-3531.
PMID: 39260742
Background: Although guidelines recommend risk assessment for hospital-acquired venous thromboembolism (HA-VTE) to inform prophylaxis decisions, studies demonstrate inappropriate utilization of pharmacoprophylaxis in hospitalized medical patients. Predictors of pharmacoprophylaxis initiation in...
3.
Zakai N, Wilkinson K, Sparks A, Gergi M, Repp A, Al-Samkari H, et al.
Res Pract Thromb Haemost
. 2024 Aug;
8(4):102483.
PMID: 39157749
No abstract available.
4.
Wilkinson K, Sparks A, Gergi M, Repp A, Al-Samkari H, Thomas R, et al.
Res Pract Thromb Haemost
. 2024 Jul;
8(4):102441.
PMID: 38953050
Background: Multiple guidelines recommend assessment of bleeding and venous thromboembolism (VTE) risk in adult medical inpatients to inform prevention strategies. There is no agreed-upon method for VTE and bleeding risk...
5.
Johansen K, Gilbertson D, Li S, Li S, Liu J, Roetker N, et al.
Am J Kidney Dis
. 2024 Mar;
83(4 Suppl 1):A8-A13.
PMID: 38519262
No abstract available.
6.
Hart A, Horak K, Roetker N, Farnum A, Murray A, Johansen K
Kidney Med
. 2024 Feb;
6(2):100770.
PMID: 38317761
Rationale & Objective: Patients with kidney failure have poor physical performance, but its trajectory is less clear. We examined physical function over the course of kidney disease, including the transition...
7.
Wetmore J, Johansen K, Gilbertson D, Roetker N
Clin J Am Soc Nephrol
. 2023 Nov;
19(1):101-107.
PMID: 37962893
How symptoms recorded in the electronic health record change during the transition to dialysis has not been fully explored. We used the Optum deidentified Integrated Claims-Clinical dataset to identify individuals...
8.
Zakai N, Wilkinson K, Sparks A, Packer R, Koh I, Roetker N, et al.
J Thromb Haemost
. 2023 Nov;
22(2):503-515.
PMID: 37918635
Background: Regulatory organizations recommend assessing hospital-acquired (HA) venous thromboembolism (VTE) risk for medical inpatients. Objectives: To develop and validate a risk assessment model (RAM) for HA-VTE in medical inpatients using...
9.
Thomas R, Wilkinson K, Koh I, Li A, Warren J, Roetker N, et al.
Res Pract Thromb Haemost
. 2023 Jun;
7(4):100162.
PMID: 37342252
Background: Accurate and efficient methods to identify venous thromboembolism (VTE) events in hospitalized people are needed to support large-scale studies. Validated computable phenotypes using a specific combination of discrete, searchable...
10.
Meyer M, Wetmore J, Weinhandl E, Roetker N
Am J Cardiol
. 2023 May;
197:68-74.
PMID: 37150720
Heart failure (HF) with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are interrelated and often coexisting conditions in older adults. Although equally recommended, nondihydropyridine calcium channel blockers (non-DHP CCBs),...